M Nazmul Huda1,2,3, Shaikh M Ahmad2, Karen M Kalanetra4, Diana H Taft4, Md J Alam2, Afsana Khanam2, Rubhana Raqib2, Mark A Underwood5, David A Mills4,6, Charles B Stephensen1,3. 1. Nutrition Department. 2. Immunobiology, Nutrition and Toxicology Laboratory, Infectious Diseases Division, icddr,b, Dhaka, Bangladesh. 3. US Department of Agriculture, Western Human Nutrition Research Center, Davis, CA. 4. Department of Food Science and Technology. 5. Department of Pediatrics, University of California, Davis, Sacramento, CA. 6. Department of Viticulture and Enology, University of California, Davis, Davis, CA.
Abstract
BACKGROUND: Infancy is a crucial period for establishing the intestinal microbiome. This process may be influenced by vitamin A (VA) status because VA affects intestinal immunity and epithelial integrity, factors that can, in turn, modulate microbiome development. OBJECTIVES: The aim of this study was to determine if neonatal VA supplementation (VAS) affected the abundance of Bifidobacterium, a beneficial commensal, or of Proteobacteria, a phylum containing enteric pathogens, in early (6-15 wk) or late (2 y) infancy. Secondary objectives were to determine if VAS affected the abundance of other bacterial taxa, and to determine if VA status assessed by measuring plasma retinol was associated with bacterial abundance. METHODS:Three hundred and six Bangladeshi infants were randomized by sex and birthweight status (above/below median) to receive 1 VA dose (50,000 IU) or placebo within 48 h of birth. Relative abundance at the genus level and above was assessed by 16S rRNA gene sequencing. A terminal restriction fragment-length polymorphism assay was used to identify Bifidobacterium species and subspecies at 6 wk. RESULTS: Linear regression showed that Bifidobacterium abundance in early infancy was lower in boys (median, 1st/3rd quartiles; 0.67, 0.52/0.78) than girls (0.73, 0.60/0.80; P = 0.003) but that boys receiving VAS (0.69, 0.55/0.78) had higher abundance than boys receiving placebo (0.65, 0.44/0.77; P = 0.039). However this difference was not seen in girls (VAS 0.71, 0.54/0.80; placebo 0.75, 0.63/0.81; P = 0.25). VAS did not affect Proteobacteria abundance. Sex-specific associations were also seen for VA status, including positive associations of plasma retinol with Actinobacteria (the phylum containing Bifidobacterium) and Akkermansia, another commensal with possible health benefits, for girls in late infancy. CONCLUSIONS: Better VA status in infancy may influence health both in infancy and later in life by promoting the establishment of a healthy microbiota. This postulated effect of VA may differ between boys and girls. This trial was registered at clinicaltrials.gov as NCT02027610. Published by Oxford University Press on behalf of the American Society for Nutrition 2019.
RCT Entities:
BACKGROUND: Infancy is a crucial period for establishing the intestinal microbiome. This process may be influenced by vitamin A (VA) status because VA affects intestinal immunity and epithelial integrity, factors that can, in turn, modulate microbiome development. OBJECTIVES: The aim of this study was to determine if neonatal VA supplementation (VAS) affected the abundance of Bifidobacterium, a beneficial commensal, or of Proteobacteria, a phylum containing enteric pathogens, in early (6-15 wk) or late (2 y) infancy. Secondary objectives were to determine if VAS affected the abundance of other bacterial taxa, and to determine if VA status assessed by measuring plasma retinol was associated with bacterial abundance. METHODS: Three hundred and six Bangladeshi infants were randomized by sex and birthweight status (above/below median) to receive 1 VA dose (50,000 IU) or placebo within 48 h of birth. Relative abundance at the genus level and above was assessed by 16S rRNA gene sequencing. A terminal restriction fragment-length polymorphism assay was used to identify Bifidobacterium species and subspecies at 6 wk. RESULTS: Linear regression showed that Bifidobacterium abundance in early infancy was lower in boys (median, 1st/3rd quartiles; 0.67, 0.52/0.78) than girls (0.73, 0.60/0.80; P = 0.003) but that boys receiving VAS (0.69, 0.55/0.78) had higher abundance than boys receiving placebo (0.65, 0.44/0.77; P = 0.039). However this difference was not seen in girls (VAS 0.71, 0.54/0.80; placebo 0.75, 0.63/0.81; P = 0.25). VAS did not affect Proteobacteria abundance. Sex-specific associations were also seen for VA status, including positive associations of plasma retinol with Actinobacteria (the phylum containing Bifidobacterium) and Akkermansia, another commensal with possible health benefits, for girls in late infancy. CONCLUSIONS: Better VA status in infancy may influence health both in infancy and later in life by promoting the establishment of a healthy microbiota. This postulated effect of VA may differ between boys and girls. This trial was registered at clinicaltrials.gov as NCT02027610. Published by Oxford University Press on behalf of the American Society for Nutrition 2019.
Authors: Hana Kozakova; Lars A Hanson; Renata Stepankova; Helena Kahu; Ulf I Dahlgren; Ursula Wiedermann Journal: Microbes Infect Date: 2003-04 Impact factor: 2.700
Authors: Andressa A F L Maciel; Reinaldo B Oriá; Manuel B Braga-Neto; Andréa B Braga; Eunice B Carvalho; Herene B M Lucena; Gerly A C Brito; Richard L Guerrant; Aldo A M Lima Journal: Toxicon Date: 2007-07-31 Impact factor: 3.033
Authors: J Gregory Caporaso; Justin Kuczynski; Jesse Stombaugh; Kyle Bittinger; Frederic D Bushman; Elizabeth K Costello; Noah Fierer; Antonio Gonzalez Peña; Julia K Goodrich; Jeffrey I Gordon; Gavin A Huttley; Scott T Kelley; Dan Knights; Jeremy E Koenig; Ruth E Ley; Catherine A Lozupone; Daniel McDonald; Brian D Muegge; Meg Pirrung; Jens Reeder; Joel R Sevinsky; Peter J Turnbaugh; William A Walters; Jeremy Widmann; Tanya Yatsunenko; Jesse Zaneveld; Rob Knight Journal: Nat Methods Date: 2010-04-11 Impact factor: 28.547
Authors: Janine L Coombes; Karima R R Siddiqui; Carolina V Arancibia-Cárcamo; Jason Hall; Cheng-Ming Sun; Yasmine Belkaid; Fiona Powrie Journal: J Exp Med Date: 2007-07-09 Impact factor: 14.307
Authors: Shaikh M Ahmad; M Nazmul Huda; Rubhana Raqib; Firdausi Qadri; Md Jahangir Alam; Md Nure Alam Afsar; Janet M Peerson; Sherry A Tanumihardjo; Charles B Stephensen Journal: J Nutr Date: 2020-11-19 Impact factor: 4.798
Authors: Anna N Ligezka; A Irem Sonmez; Martha P Corral-Frias; Raphael Golebiowski; Brian Lynch; Paul E Croarkin; Magdalena Romanowicz Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2020-12-01 Impact factor: 5.201
Authors: Amy M Ehrlich; Alline R Pacheco; Bethany M Henrick; Diana Taft; Gege Xu; M Nazmul Huda; Darya Mishchuk; Michael L Goodson; Carolyn Slupsky; Daniela Barile; Carlito B Lebrilla; Charles B Stephensen; David A Mills; Helen E Raybould Journal: BMC Microbiol Date: 2020-11-23 Impact factor: 3.605
Authors: Annica R Stull-Lane; Kristen L Lokken-Toyli; Vladimir E Diaz-Ochoa; Gregory T Walker; Stephanie A Cevallos; Andromeda L N Winter; Ariel Del Hoyo Muñoz; Guiyan G Yang; Eric M Velazquez; Chun-Yi Wu; Renée M Tsolis Journal: PLoS Negl Trop Dis Date: 2020-10-02